1ClBlS Ⅱ investigators and committees.The Cardial lnsufficiency Bisoprolol Study Ⅱ(ClBlS-Ⅱ) a randomised trail. The Lancet . 1999
2Gerdes AM,Capasso JM.Structural remodeling and mechanical dysfunction of cardial myocytes in heart failure. Journal of Molecular and Cellular Cardiology . 1995
3Pitt B,Segal R,Martinez FA et al.randomised trial of losatan versus captopril in patients over 65 with heart failure. The Lancet . 1997
4Michael R Bristow.Why dose the myocardium fail?insights from basis science. The Lancet . 1998
5Lugne M.Martin P, Materl N et al.Effects of captopril related to increased levels of prostacylin and Angiotensin(1- 7)in essential hypertension. Journal of Hypertension . 1996
6Struthers AD.Aldosterone escape during ACE inhibitor therapy in chronic heart failure. European Heart Journal . 1995
7Lechat P.Prevention of heart failure progression;current approaches. European Heart Journal . 1998
8Mulder P,Richard V,Derumeaux G et al.Roles of endogenous endothelin in chronic heart failure: effect of long term treatment with an endothelin antagonist on survival, hemodynamics and cardial remodeling. Circulation . 1997
9Bryant D,Becker L,Richardson J et al.Cardial failure intrangenic mice with myocardial expression of tumer nercrosis factor-α. Circulation . 1998
10Swedberg K.for the CONSENSUS trail study group.Effects of enalapril on mortality in severe congestive heart faiure:results of the Cooperative North Scandinavian Enalapril Survival Study(CONSENSUS). The Lancet . 1997